Gyrolab Immunoassays | Automated Immunoassays | Gyros Protein Technologies
Gyros Protein Technologies' new Gyrolab Biomarker Kits
WEBINAR: Calprotectin & Complement (C4d, TCC) biomarker assays
Novartis commits $1.5B to acquire eye disease gene therapy biotech Gyroscope - MedCity News
Gyros Protein Technologies på LinkedIn: Ultra-sensitive, automated immunoassays streamline biopharma
Gyrolab Immunoassays | Automated Immunoassays | Gyros Protein Technologies
Gyros Establishes Dedicated Office in Japan | Technology Networks
Molecular Spectroscopy Evolves To Meet Changing Pharma and Biopharma Needs | Technology Networks
Nanoliter Scale Immunoassays for Time Critical Workflows - Gyros Protein Technologies
Nanoliter Scale Immunoassays for Time Critical Workflows - Gyros Protein Technologies
Gyrolab Bioaffy 4000 CD
Gyros Protein Technologies | LinkedIn
Gyros Protein Technologies debuts test for impurities in E. coli systems
Gyros Protein Technologies Upgrades Services | Contract Pharma
Automating and Miniaturizing Immunoassays
Gyros Protein Tech (@GyrosProteinTec) / Twitter
Home
Sanofi invests up to $60m in Gyroscope Therapeutics
Gyros Protein Tech (@GyrosProteinTec) / Twitter
Gyros Protein Technologies and Cygnus Technologies Expand Collaboration To Support Improved Bioprocess Impurity Analytics | Technology Networks
Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA kit reagents to support pre-clinical immunogenicity assessment - Bioanalysis Zone
Mesa Labs acquires Gyros Protein Technology
Gyros Protein Technologies signs distribution agreement with Euro Diagnostica
Gyros Protein Technologies introduces Gyrolab xPand to improve immunoassay workflow, flexibility and speed in biotherapeutic discovery, development and production | The Scientist Magazine®
Gyros expands distribution in Asia
Home
Gyros AB and Protein Technologies, Inc. merge to form Gyros Protein Technologies AB
